期刊文献+

唑来膦酸盐治疗重度绝经后骨质疏松及腰背痛的临床分析 被引量:1

下载PDF
导出
摘要 目的观察分析唑来膦酸盐治疗重度绝经后骨质疏松及腰背痛的临床疗效。方法 64例重度绝经后骨质疏松及腰背痛患者,按照治疗方法的不同分为对照组和实验组,每组32例。对照组患者给予钙剂、骨化三醇以及维生素D等常规药物治疗,实验组患者在对照组治疗基础上联合唑来膦酸盐治疗。观察比较两组患者初次入院、治疗1个疗程、3个疗程的腰背疼痛缓解情况以及腰背等关节功能改善情况。结果实验组患者治疗1个疗程后、3个疗程后视觉模拟评分法(VAS)评分分别为(4.13±0.11)、(2.51±0.07)分,均明显低于对照组的(5.73±0.18)、(4.12±0.13)分, Oswestry功能障碍指数(ODI)评分分别为(21.52±2.15)、(12.52±1.02)分,均明显低于对照组的(27.62±2.51)、(20.62±1.52)分,差异均有统计学意义(P<0.05)。结论对于重度绝经后骨质疏松及腰背痛患者在常规药物治疗基础上联合唑来膦酸盐治疗可有效改善患者腰背疼痛症状,提升腰背功能,值得临床推广。
作者 凌钦杰
出处 《中国现代药物应用》 2019年第10期115-116,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献8

二级参考文献58

  • 1Dunford JE,Thompson K,Coxon FP,et al.Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates[J].J Pharmacol Exp Ther,2001,296:235-242.
  • 2Gasser JA,Green JR.Long-term protective effect of a single IV injection of zoledronic acid on cancellous bone structure and cortical bone in ovariectomized rats[J].Bone,2002,30(3):41.
  • 3Siris ES,Harris ST,Rosen CJ,et al.Adherence to bisphosphonate therapy and fracture rates in osteoporotic women:relationship to vertebral and nonvertebral fractures from 2 US claims databases[J].Mayo Clin Proc,2006,81:1013-1022.
  • 4Black DM,Delmas PD,Eastell R,et al.Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis[J].N Engl J Med,2007,356:1809-1822.
  • 5Lyles KW,Colón Emeric CS,Magaziner JS,et al.Zoledronic acid and clinical fractures and mortality after hip fracture[J].N Engl J Med,2007,357:1799-1809.
  • 6Kim SY,Kim MJ,Cadarette SM,et al.Bisphosphonates and risk of atrial fibrillation:a meta-analysis[J].Arthritis Research & Therapy,2010,12:30.
  • 7Compston J.Treatments for osteoporosis-looking beyond the horizon[J].N Engl J Med,2007,356:18.
  • 8Cotte FE, Fardellone P, Mercier F, et al. Adherence tomonthly and weekly oral bisphosphonates in women withosteoporosis [J]. Osteoporos Int, 2010, 21 (1): 145-155.
  • 9Eriksen EF, Lyles KW, Cold Emeric CS, et al. Antifractureefficacy and reduction of mortality in relation to timing ofthe first dose of zoledronic acid after hip fracture [J]. J BoneMiner Res,2009,24(7): 1308-1313.
  • 10Reid IR, Black DM, Eastell R,et al. Reduction in the riskof clinical fractures after a single dose of zoledronic Acid5 milligrams [J]. J Clin Endocrinol Metab,2013,98(2):557-563.

共引文献53

同被引文献11

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部